These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy. Leung R; Lang B; Wong H; Chiu J; Yat WK; Shek T; Cho WY; Yau LC; Yau T Anticancer Agents Med Chem; 2013 Mar; 13(3):382-8. PubMed ID: 23092266 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumors: targeting the molecular basis of disease. Khagi S; Saif MW Curr Opin Oncol; 2015 Jan; 27(1):38-43. PubMed ID: 25390554 [TBL] [Abstract][Full Text] [Related]
14. Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors. Naraev BG; Strosberg JR; Halfdanarson TR Oncology; 2012; 83(3):117-27. PubMed ID: 22797357 [TBL] [Abstract][Full Text] [Related]